Skip to main content
OpenTrials

Clinical trial condition

Low-grade Serous Ovarian Cancer

Explore clinical trials studying Low-grade Serous Ovarian Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Low-grade Serous Ovarian Cancer trial results

Recruiting

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

NCT03564340

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
Locations
  • University of Alabama_6th Ave Birmingham, Alabama, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber / Harvard Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
View all 52 locations
View Trial Details
Recruiting

A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer

NCT06394804

Conditions
Low-grade Serous Ovarian Cancer
Locations
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
View Trial Details

Related conditions